交叉性贫血:PARP抑制剂诱导的毒性和自身免疫性血液溶解-一个病例报告
Julien Dereme1, Konstantinos Asonitis2, Francesco Grandoni1
1Service and Central Laboratory of Haematology Department of Oncology and Department of Laboratories and Pathology Lausanne University Hospital (CHUV) and University of Lausanne (UNIL) Lausanne Switzerland.
EJHaem
|July 30, 2025
概括
本案例研究详细介绍了卵巢癌患者的严重贫血,这可能是由长期的PARP抑制剂毒性和温暖的自身抗体引起的. 及时的皮质类固醇治疗导致了显著的血液学改善.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一名71岁的患有高度血清性卵巢腺癌的妇女接受了新辅助和辅助化疗,随后接受了贝瓦齐祖马布和奥拉帕里布的维持疗法.
- 神经学并发症导致停止服用贝瓦西祖马布,之后患者患上严重的渐进性贫血 (血红蛋白低至54g/L).
研究的目的:
- 在接受卵巢癌治疗的患者中调查严重贫血的复杂病因.
- 突出管理药物诱导的血液毒性和重叠条件的挑战.
主要方法:
- 检查了患者的治疗史,包括化疗,手术和使用贝瓦齐祖马布和奥拉巴里布的维持治疗.
- 诊断工作包括排除常见的贫血原因,骨髓活检和对自身抗体的评估.
- 评估了对高剂量皮质类固醇治疗的反应.
主要成果:
- 骨髓活检显示了克隆性细胞毒性T-LGL群体和DNMT3A突变,没有骨髓扩张或转移的证据.
- 患者产生热性自身抗体 (IgG) 和网状细胞的减少,表明混合性贫血特征.
- 高剂量的皮质类固醇诱导了迅速的血液学改善,解决了输血依赖.
结论:
- 严重的贫血很可能是混合来源的,涉及长期PARP抑制剂 (olaparib) 毒性的低再生成分和由于温暖的自身抗体而导致的溶血机制.
- 包括DNMT3A突变和T-LGL克隆在内的混因素使诊断和管理复杂化.
- 这一案例强调了全面的血液学评估在治疗癌症患者复杂的药物诱导毒性和重叠状况方面的重要性.
相关概念视频
Disorders of Erythrocytes
1.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.3K
Autoimmune Disorders
677
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
677
Gastritis-II: Pathophysiology
556
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
556
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
108
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
108
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Blood Transfusion and Agglutination
11.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.2K


